Stražar Klemen, Slodnjak Ivan, Zupanc Oskar, Drobnič Matej
1 Department of Orthopaedic Surgery, University Medical Centre Ljubljana, Zaloška 9, SI-1000 Ljubljana, Slovenia.
2 Clinic for Nuclear Medicine, University Medical Centre Ljubljana, Zaloška 7, SI-1000 Ljubljana, Slovenia.
Hip Int. 2019 May;29(3):328-335. doi: 10.1177/1120700018782274. Epub 2018 Jun 22.
The aim was to present the surgical technique and clinical outcome in a series of patients treated with gamma-probe-assisted arthroscopic removal of osteoid osteoma in the hip joint.
The case series consisted of 10 patients diagnosed with osteoid osteoma of the hip, who were treated by arthroscopic nidus removal. An endoscopic gamma probe was used intraoperatively to locate the nidus and to control the extent of its removal. Residual osteoma cavities were additionally treated with an arthroscopic radiofrequency ablator. Microfracturing was performed when the osteochondral defect was in the weight-bearing area and osteochondroplasty was done in cases of concomitant cam deformity. Nonarthritic Hip Score (NAHS), Tegner activity score, quality of life questionnaire (EQ-5D) and postoperative magnetic resonance imaging (MRI) were used for evaluation before and post-surgery, with a minimum follow-up of 2 years.
The relative reduction of the gamma irradiation count immediately after removal of the nidus was 44.9% (range 33.3-54.5%). Postoperatively, all patients experienced prompt pain relief and a significant improvement according to all patient reported outcomes. Control MRI revealed fibro-cartilaginous tissue repair of post-osteoma osteochondral defects in the weight-bearing area; 1 patient showed signs of early degeneration.
The results of this case series demonstrated the safety and high efficacy of gamma-probe-assisted arthroscopic removal of the osteoid osteoma from the hip joint. Endoscopic gamma probe was recognised as a very useful device for locating the nidus of the osteoid osteoma exactly and preventing incomplete or excessive removal of the bone.
本研究旨在介绍一系列采用γ探头辅助关节镜下切除髋关节骨样骨瘤的手术技术及临床疗效。
该病例系列包括10例诊断为髋关节骨样骨瘤的患者,均接受关节镜下瘤巢切除术。术中使用内镜γ探头定位瘤巢并控制切除范围。对于残留的骨瘤腔,额外使用关节镜射频消融器进行处理。当骨软骨缺损位于负重区时行微骨折术,合并凸轮畸形时行骨软骨成形术。术前及术后采用非关节炎髋关节评分(NAHS)、特格纳活动评分、生活质量问卷(EQ-5D)及术后磁共振成像(MRI)进行评估,随访时间至少2年。
瘤巢切除后γ射线计数立即相对减少44.9%(范围33.3%-54.5%)。术后,所有患者均迅速缓解疼痛,且所有患者报告的结局均有显著改善。对照MRI显示负重区骨样骨瘤骨软骨缺损处有纤维软骨组织修复;1例患者出现早期退变迹象。
本病例系列结果表明,γ探头辅助关节镜下切除髋关节骨样骨瘤具有安全性和高效性。内镜γ探头被认为是一种非常有用的设备,可精确定位骨样骨瘤的瘤巢,并防止骨切除不完全或过度。